Liang‐Ru Ke

1.3k total citations
37 papers, 767 citations indexed

About

Liang‐Ru Ke is a scholar working on Otorhinolaryngology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Liang‐Ru Ke has authored 37 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Otorhinolaryngology, 20 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Liang‐Ru Ke's work include Head and Neck Cancer Studies (20 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Viral-associated cancers and disorders (6 papers). Liang‐Ru Ke is often cited by papers focused on Head and Neck Cancer Studies (20 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Viral-associated cancers and disorders (6 papers). Liang‐Ru Ke collaborates with scholars based in China, United States and Hong Kong. Liang‐Ru Ke's co-authors include Xing Lv, Wei‐Xiong Xia, Yan‐Qun Xiang, Xiang Guo, Hu L, Ya‐Hui Yu, Yan‐Fang Ye, Bo Zhao, Bingzhong Jing and Kui‐Yuan Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Liang‐Ru Ke

35 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liang‐Ru Ke China	18	291	239	198	140	125	37	767
Stephanie G. Craig United Kingdom	17	314 1.1×	257 1.1×	95 0.5×	92 0.7×	130 1.0×	49	796
Wei‐Xiong Xia China	19	408 1.4×	188 0.8×	430 2.2×	135 1.0×	156 1.2×	65	912
Hai‐Qiang Mai China	16	297 1.0×	301 1.3×	310 1.6×	79 0.6×	172 1.4×	53	888
Jingao Li China	18	297 1.0×	329 1.4×	408 2.1×	162 1.2×	187 1.5×	85	1.1k
H Helin Finland	17	203 0.7×	252 1.1×	43 0.2×	93 0.7×	86 0.7×	35	788
Lingkang Huang United States	15	548 1.9×	153 0.6×	71 0.4×	26 0.2×	181 1.4×	29	824
Changming An China	14	151 0.5×	481 2.0×	72 0.4×	29 0.2×	292 2.3×	68	819
Lan Peng United States	12	285 1.0×	187 0.8×	24 0.1×	137 1.0×	132 1.1×	27	703
Jiaqi Han China	15	167 0.6×	254 1.1×	30 0.2×	54 0.4×	134 1.1×	69	664
Shaobo Liang China	19	448 1.5×	197 0.8×	802 4.1×	234 1.7×	186 1.5×	58	1.3k

Countries citing papers authored by Liang‐Ru Ke

Since Specialization

Citations

This map shows the geographic impact of Liang‐Ru Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Ru Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Ru Ke more than expected).

Fields of papers citing papers by Liang‐Ru Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐Ru Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Ru Ke. The network helps show where Liang‐Ru Ke may publish in the future.

Co-authorship network of co-authors of Liang‐Ru Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Ru Ke. A scholar is included among the top collaborators of Liang‐Ru Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Ru Ke. Liang‐Ru Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Yishu, Yingying Huang, Haijun Wu, et al.. (2025). Establishment of a deep-learning-assisted recurrent nasopharyngeal carcinoma detecting simultaneous tactic (DARNDEST) with high cost-effectiveness based on magnetic resonance images: a multicenter study in an endemic area. Cancer Imaging. 25(1). 39–39.

Cao, Xun, Han-Ying Huang, Jiayu Zhou, et al.. (2025). Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. Clinical Cancer Research. 31(15). 3133–3141. 1 indexed citations

Wang, Lin, Nian Lu, Cheng Xu, et al.. (2025). Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial. BMC Medicine. 23(1). 152–152. 1 indexed citations

Cao, Xun, Jiayu Zhou, Xi Chen, et al.. (2024). Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial. Nature Communications. 15(1). 949–949. 5 indexed citations

Shen, Lujun, Yiquan Jiang, Jia‐Tao Zhang, et al.. (2024). Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC Model. Cancer Informatics. 23. 2683916279–2683916279.

Huang, Yingying, Jiayu Zhou, Liang‐Ru Ke, et al.. (2023). Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose. BMC Cancer. 23(1). 410–410. 2 indexed citations

Chen, Xi, Yingxue Li, Xun Cao, et al.. (2023). Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma. Lipids in Health and Disease. 22(1). 81–81. 5 indexed citations

Deng, Yishu, Yingying Huang, Bingzhong Jing, et al.. (2023). Deep learning-based recurrence detector on magnetic resonance scans in nasopharyngeal carcinoma: A multicenter study. European Journal of Radiology. 168. 111084–111084. 4 indexed citations

Wang, Chong, Luyao Zhang, Liang‐Ru Ke, et al.. (2020). Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nature Communications. 11(1). 6318–6318. 24 indexed citations

10.

Shen, Lujun, Qifeng Chen, Changsheng Yang, et al.. (2020). Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis. Frontiers in Pharmacology. 11. 593195–593195. 18 indexed citations

11.

Jing, Bingzhong, Tao Zhang, Zixian Wang, et al.. (2019). A deep survival analysis method based on ranking. Artificial Intelligence in Medicine. 98. 1–9. 54 indexed citations

12.

Wang, Chong, Sizun Jiang, Liang‐Ru Ke, et al.. (2019). Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma. Journal of Biological Chemistry. 294(25). 9734–9745. 10 indexed citations

13.

Li, Wang‐Zhong, Kangqiang Peng, Xing Lv, et al.. (2019). Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma. Cancer Medicine. 9(3). 920–930. 5 indexed citations

14.

Yu, Ya‐Hui, Hu L, Xing Lv, et al.. (2018). Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area. Journal of Cancer Research and Clinical Oncology. 144(11). 2231–2243. 7 indexed citations

15.

Yu, Ya‐Hui, Liang‐Ru Ke, Xing Lv, et al.. (2018). The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma. Cancer Management and Research. Volume 10. 1935–1946. 37 indexed citations

16.

L, Hu, Wei‐Xiong Xia, Xing Lv, et al.. (2017). Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial (ChiCTR-TRC-12001979).. Journal of Clinical Oncology. 35(15_suppl). 6006–6006. 15 indexed citations

17.

Yu, Ya‐Hui, Wei‐Xiong Xia, Junli Shi, et al.. (2016). A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients. Chinese Journal of Cancer. 35(1). 59–59. 31 indexed citations

18.

Ke, Liang‐Ru, Yan‐Qun Xiang, Wei‐Xiong Xia, et al.. (2016). A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage. Clinical Immunology. 164. 45–51. 28 indexed citations

19.

Xia, Wei‐Xiong, Yan‐Fang Ye, Xing Lü, et al.. (2013). The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy. PLoS ONE. 8(10). e76958–e76958. 23 indexed citations

20.

Chen, Minying, et al.. (2013). Liver function is affected by mechanical ventilation after abdominal surgery. Journal of the American College of Surgeons. 217(3). S56–S57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact